DRD2 and schizophrenia: Four candidate genes (DRD2, COMT, 5-HTR2A, and SLC6A4) from dopaminergic and serotoninergic pathways have received the most attention in the literature and have been supposed as the promising candidate genes for schizophrenia and treatment response (15–19).